Title |
The Role of TDP-43 in Alzheimer’s Disease
|
---|---|
Published in |
Molecular Neurobiology, June 2015
|
DOI | 10.1007/s12035-015-9264-5 |
Pubmed ID | |
Authors |
Xiao-Long Chang, Meng-Shan Tan, Lan Tan, Jin-Tai Yu |
Abstract |
The transactive response DNA binding protein (TDP-43) has long been characterized as a main hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U, also known as FTLD-TDP). Several studies have indicated TDP-43 deposits in Alzheimer's disease (AD) brains and have robust connection with AD clinical phenotype. FTLD-U, which was symptomatically connected with AD, may be predictable for the comprehension of the role TDP-43 in AD. TDP-43 may contribute to AD through both β-amyloid (Aβ)-dependent and Aβ-independent pathways. In this article, we summarize the latest studies concerning the role of TDP-43 in AD and explore TDP-43 modulation as a potential therapeutic strategy for AD. However, to date, little of pieces of the research on TDP-43 have been performed to investigate the role in AD; more investigations need to be confirmed in the future. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 60% |
Guinea | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 124 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 29 | 23% |
Researcher | 13 | 10% |
Student > Bachelor | 12 | 10% |
Student > Master | 10 | 8% |
Student > Doctoral Student | 9 | 7% |
Other | 23 | 19% |
Unknown | 28 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 23 | 19% |
Biochemistry, Genetics and Molecular Biology | 22 | 18% |
Medicine and Dentistry | 17 | 14% |
Agricultural and Biological Sciences | 16 | 13% |
Engineering | 4 | 3% |
Other | 12 | 10% |
Unknown | 30 | 24% |